Results 31 to 40 of about 48,580 (292)

Draft genome sequence of Stenotrophomonas maltophilia strain P13 gives insight into its protease production and assessment of sulfur and nitrogen metabolism

Current Research in Microbial Sciences, 2021
Stenotrophomonas maltophilia strain P13 was isolated from the Kanchengayao glacier's accumulation zone. A comprehensive study was done on this strain as it produced protease enzyme and thus having industrial potential.
Mingma Thundu Sherpa, Sayak Das, Ishfaq Nabi Najar, Nagendra Thakur   +3 more
doaj   +1 more source

p13 ct

, 2021
1
openaire   +2 more sources

Biosimilars in Pediatric Inflammatory Bowel Diseases: A Systematic Review and Real Life-Based Evidence

Frontiers in Pharmacology, 2022
Background: Many pediatric inflammatory bowel disease (IBD) patients are now using biosimilars of anti-tumor necrosis factor-α (TNF-α), with increasing trends in recent years.
Valeria Dipasquale, Giuseppe Cicala, Edoardo Spina, Claudio Romano   +3 more
doaj   +1 more source

The Antimicrobial, Antibiofilm and Anti-Inflammatory Activities of P13#1, a Cathelicidin-like Achiral Peptoid

Pharmaceuticals, 2023
Cationic antimicrobial peptides (CAMPs) are powerful molecules with antimicrobial, antibiofilm and endotoxin-scavenging activities. These properties make CAMPs very attractive drugs in the face of the rapid increase in multidrug-resistant (MDR) pathogens,
Valeria Cafaro, Andrea Bosso, Ilaria Di Nardo, Assunta D’Amato, Irene Izzo, Francesco De Riccardis, Marialuisa Siepi, Rosanna Culurciello, Nunzia D’Urzo, Emiliano Chiarot, Antonina Torre, Elio Pizzo, Marcello Merola, Eugenio Notomista   +13 more
doaj   +1 more source

t(4;12)(q21;p13) [PDF]

, 2019
Review on t(4;12)(q21;p13) in lymphoid ...
Gindina, Tatiana
core   +1 more source

HTLV-1 p13 Protein Hijacks Macrophage Polarization and Promotes T-Cell Recruitment

Viruses
The human T-cell leukemia type-1 (HTLV-1) retrovirus establishes chronic life-long infection in a fraction of infected individuals associated with severe pathological conditions. Although the mechanism driving disease development is not fully understood,
Ramona Moles, Maria Omsland, Cynthia A. Pise-Masison, Jeffrey J. Subleski, Daniel W. McVicar, Sarkis Sarkis, Anna Gutowska, Luca Schifanella, Melvin Doster, Robyn Washington-Parks, Vincenzo Ciminale, Genoveffa Franchini   +11 more
doaj   +1 more source

t(1;19)(p13;p13.1) [PDF]

, 2016
Review on t(1;19)(p13;p13.1), with data on ...
Al Bahar, Soad, Zamecnikova, Adriana
core   +1 more source

A Prospective Observational Study on the Efficacy and Safety of Infliximab-Biosimilar (CT-P13) in Patients With Takayasu Arteritis (TAKASIM)

Frontiers in Medicine, 2021
Objectives: Infliximab (IFX) is widely used in patients with refractory Takayasu arteritis (TAK). Recently, the IFX-biosimilar CT-P13 has been introduced for the treatment of inflammatory diseases.
Corrado Campochiaro, Corrado Campochiaro, Alessandro Tomelleri, Alessandro Tomelleri, Silvia Sartorelli, Camilla Sembenini, Maurizio Papa, Federico Fallanca, Maria Picchio, Maria Picchio, Giulio Cavalli, Giulio Cavalli, Francesco De Cobelli, Francesco De Cobelli, Elena Baldissera, Lorenzo Dagna, Lorenzo Dagna   +16 more
doaj   +1 more source

Current status of biosimilars in the treatment of inflammatory bowel diseases [PDF]

Intestinal Research, 2016
Introduction of biological therapies have led to dramatic changes in the management of debilitating immune-mediated inflammatory bowel diseases (IBD) including ulcerative colitis and Crohn's disease. However, the long term use of these agents may be very
Dong Il Park
doaj   +1 more source

t(12;14)(p13;q32) [PDF]

, 2006
Review on t(12;14)(p13;q32), with data on clinics, and the genes ...
Huret, JL
core   +1 more source